HYPEROXALURIA (DISORDER)

Clinical trials for HYPEROXALURIA (DISORDER) explained in plain language.

Never miss a new study

Get alerted when new HYPEROXALURIA (DISORDER) trials appear

Sign up with your email to follow new studies for HYPEROXALURIA (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Oxalate excretion profile in patients with a heterozygous mutation of the AGXT (Alanine-glyoxylate aminotransferase) gene - influence of hygienic and dietary conditions and identification of favouring factors by comparison of asymptomatic and symptomatic patients (Lithiasis or oxalic nephropathy)

Completed

Primary hyperoxaluria type I (PH1) is a rare genetic disorder responsible for severe lithiasis leading to progressive deterioration of renal function and end-stage renal failure. PH1 is linked to a deficiency in glyoxylate amino transferase (AGXT), which leads to increased endoge…

Matched conditions: HYPEROXALURIA (DISORDER)

Phase: NA • Sponsor: Hospices Civils de Lyon

Last updated May 07, 2026 18:39 UTC

HYPEROXALURIA (DISORDER)

Get alerted when new HYPEROXALURIA (DISORDER) trials appear

Oxalate excretion profile in patients with a heterozygous mutation of the AGXT (Alanine-glyoxylate aminotransferase) gene - influence of hygienic and dietary conditions and identification of favouring factors by comparison of asymptomatic and symptomatic patients (Lithiasis or oxalic nephropathy)